United States Subcutaneous Biologics Industry 2016 Market Research Report Research N Reports

Home / Pharma Healthcare / United States Subcutaneous Biologics Industry 2016 Market Research Report

United States Subcutaneous Biologics Industry 2016 Market Research Report

Id : RNR-3123
Category : Pharma Healthcare
Publish Date : 20/Jun
Pages : 130
Format : PDF

DESCRIPTION TABLE OF CONTENTS ASK FOR DISCOUNT Request Sample Enquiry Before Buying

License Type

Description

The United States Subcutaneous Biologics Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Subcutaneous Biologics industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Subcutaneous Biologics market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Subcutaneous Biologics industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 141 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of contents

Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Subcutaneous Biologics
    1.1.1 Definition of Subcutaneous Biologics
    1.1.2 Specifications of Subcutaneous Biologics
1.2 Classification of Subcutaneous Biologics
    1.2.1 Insulin Pumps with Infusion Sets
    1.2.2 Insulin Patch Pumps
    1.2.3 Transdermal Patch
    1.2.4 Bolus Injectors
1.3 Applications of Subcutaneous Biologics
1.4 Industry Chain Structure of Subcutaneous Biologics
1.5 Industry Overview of Subcutaneous Biologics
1.6 Industry Policy Analysis of Subcutaneous Biologics
1.7 Industry News Analysis of Subcutaneous Biologics

2 Manufacturing Cost Structure Analysis of Subcutaneous Biologics
2.1 Bill of Materials (BOM) of Subcutaneous Biologics
2.2 BOM Price Analysis of Subcutaneous Biologics
2.3 Labor Cost Analysis of Subcutaneous Biologics
2.4 Depreciation Cost Analysis of Subcutaneous Biologics
2.5 Manufacturing Cost Structure Analysis of Subcutaneous Biologics
2.6 Manufacturing Process Analysis of Subcutaneous Biologics
2.7 United States Price, Cost and Gross of Subcutaneous Biologics 2011-2016

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Subcutaneous Biologics Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Subcutaneous Biologics Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Subcutaneous Biologics Key Manufacturers in 2015

4 Production Analysis of Subcutaneous Biologics by Regions, Type, and Applications
4.1 United States Production of Subcutaneous Biologics by Regions 2011-2016
4.2 United States Production of Subcutaneous Biologics by Type 2011-2016
4.3 United States Sales of Subcutaneous Biologics by Applications 2011-2016
4.4 Price Analysis of United States Subcutaneous Biologics Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Subcutaneous Biologics 2011-2016

5 Consumption Volume and Consumption Value Analysis of Subcutaneous Biologics by Regions
5.1 United States Consumption Volume of Subcutaneous Biologics by Regions 2011-2016
5.2 United States Consumption Value of Subcutaneous Biologics by Regions 2011-2016
5.3 United States Consumption Price Analysis of Subcutaneous Biologics by Regions 2011-2016

6 Analysis of Subcutaneous Biologics Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Subcutaneous Biologics 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Subcutaneous Biologics 2014-2015
6.3 Sales Overview of Subcutaneous Biologics 2011-2016
6.4 Supply, Consumption and Gap of Subcutaneous Biologics 2011-2016
6.5 Import, Export and Consumption of Subcutaneous Biologics 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Subcutaneous Biologics 2011-2016

7 Analysis of Subcutaneous Biologics Industry Key Manufacturers
7.1 Abbott Laboratories
    7.1.1 Company Profile
    7.1.2 Product Picture and Specifications
        7.1.2.1 Type I
        7.1.2.2 Type II
        7.1.2.3 Type III
    7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.1.4 Contact Information

7.2 Activa
    7.2.1 Company Profile
    7.2.2 Product Picture and Specifications
        7.2.2.1 Type I
        7.2.2.2 Type II
        7.2.2.3 Type III
    7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.2.4 Contact Information

7.3 Adamis Pharmaceuticals Corporation
    7.3.1 Company Profile
    7.3.2 Product Picture and Specifications
        7.3.2.1 Type I
        7.3.2.2 Type II
        7.3.2.3 Type III
    7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.3.4 Contact Information

7.4 ADOCIA
    7.4.1 Company Profile
    7.4.2 Product Picture and Specifications
        7.4.2.1 Type I
        7.4.2.2 Type II
        7.4.2.3 Type III
    7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.4.4 Contact Information

7.5 Advantage Health Services
    7.5.1 Company Profile
    7.5.2 Product Picture and Specifications
        7.5.2.1 Type I
        7.5.2.2 Type II
        7.5.2.3 Type III
    7.5.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.5.4 Contact Information

7.6 Aguettant
    7.6.1 Company Profile
    7.6.2 Product Picture and Specifications
        7.6.2.1 Type I
        7.6.2.2 Type II
        7.6.2.3 Type III
    7.6.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.6.4 Contact Information

7.7 Ajinomoto Althea Inc.
    7.7.1 Company Profile
    7.7.2 Product Picture and Specifications
        7.7.2.1 Type I
        7.7.2.2 Type II
        7.7.2.3 Type III
    7.7.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.7.4 Contact Information

7.8 Alnylam Pharmaceuticals
    7.8.1 Company Profile
    7.8.2 Product Picture and Specifications
        7.8.2.1 Type I
        7.8.2.2 Type II
        7.8.2.3 Type III
    7.8.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.8.4 Contact Information

7.9 Amgen
    7.9.1 Company Profile
    7.9.2 Product Picture and Specifications
        7.9.2.1 Type I
        7.9.2.2 Type II
        7.9.2.3 Type III
    7.9.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.9.4 Contact Information

7.10 Antares Pharma
    7.10.1 Company Profile
    7.10.2 Product Picture and Specifications
        7.10.2.1 Type I
        7.10.2.2 Type II
        7.10.2.3 Type III
    7.10.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.10.4 Contact Information

7.11 Aptar Pharm
    7.11.1 Company Profile
    7.11.2 Product Picture and Specifications
        7.11.2.1 Type I
        7.11.2.2 Type II
        7.11.2.3 Type III
    7.11.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.11.4 Contact Information

7.12 Aradigm Corporation
    7.12.1 Company Profile
    7.12.2 Product Picture and Specifications
        7.12.2.1 Type I
        7.12.2.2 Type II
        7.12.2.3 Type III
    7.12.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.12.4 Contact Information

7.13 Arte Corporation
    7.13.1 Company Profile
    7.13.2 Product Picture and Specifications
        7.13.2.1 Type I
        7.13.2.2 Type II
        7.13.2.3 Type III
    7.13.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.13.4 Contact Information

7.14 Ascendis Pharma
    7.14.1 Company Profile
    7.14.2 Product Picture and Specifications
        7.14.2.1 Type I
        7.14.2.2 Type II
        7.14.2.3 Type III
    7.14.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.14.4 Contact Information

7.15 AstraZeneca
    7.15.1 Company Profile
    7.15.2 Product Picture and Specifications
        7.15.2.1 Type I
        7.15.2.2 Type II
        7.15.2.3 Type III
    7.15.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.15.4 Contact Information

7.16 Bang and Olufsen
    7.16.1 Company Profile
    7.16.2 Product Picture and Specifications
        7.16.2.1 Type I
        7.16.2.2 Type II
        7.16.2.3 Type III
    7.16.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.16.4 Contact Information

7.17 Battelle
    7.17.1 Company Profile
    7.17.2 Product Picture and Specifications
        7.17.2.1 Type I
        7.17.2.2 Type II
        7.17.2.3 Type III
    7.17.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.17.4 Contact Information

7.18 Baxter
    7.18.1 Company Profile
    7.18.2 Product Picture and Specifications
        7.18.2.1 Type I
        7.18.2.2 Type II
        7.18.2.3 Type III
    7.18.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.18.4 Contact Information

7.19 Bayer
    7.19.1 Company Profile
    7.19.2 Product Picture and Specifications
        7.19.2.1 Type I
        7.19.2.2 Type II
        7.19.2.3 Type III
    7.19.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.19.4 Contact Information

7.20 Becton Dickinson
    7.20.1 Company Profile
    7.20.2 Product Picture and Specifications
        7.20.2.1 Type I
        7.20.2.2 Type II
        7.20.2.3 Type III
    7.20.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.20.4 Contact Information

7.21 Bespak
    7.21.1 Company Profile
    7.21.2 Product Picture and Specifications
        7.21.2.1 Type I
        7.21.2.2 Type II
        7.21.2.3 Type III
    7.21.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.21.4 Contact Information

7.22 Biogen Idec
    7.22.1 Company Profile
    7.22.2 Product Picture and Specifications
        7.22.2.1 Type I
        7.22.2.2 Type II
        7.22.2.3 Type III
    7.22.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.22.4 Contact Information

7.23 Bioject Medical Technologies, Inc.
    7.23.1 Company Profile
    7.23.2 Product Picture and Specifications
        7.23.2.1 Type I
        7.23.2.2 Type II
        7.23.2.3 Type III
    7.23.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.23.4 Contact Information

7.24 Bristol-Myers Squibb Co
    7.24.1 Company Profile
    7.24.2 Product Picture and Specifications
        7.24.2.1 Type I
        7.24.2.2 Type II
        7.24.2.3 Type III
    7.24.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.24.4 Contact Information

7.25 Calibra Medical
    7.25.1 Company Profile
    7.25.2 Product Picture and Specifications
        7.25.2.1 Type I
        7.25.2.2 Type II
        7.25.2.3 Type III
    7.25.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.25.4 Contact Information

7.26 CeQur SA
    7.26.1 Company Profile
    7.26.2 Product Picture and Specifications
        7.26.2.1 Type I
        7.26.2.2 Type II
        7.26.2.3 Type III
    7.26.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.26.4 Contact Information

8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Subcutaneous Biologics Product Types
8.5 Market Share Analysis of Different Subcutaneous Biologics Price Levels
8.6 Gross Margin Analysis of Different Subcutaneous Biologics Applications

9 Marketing Trader or Distributor Analysis of Subcutaneous Biologics
9.1 Marketing Channels Status of Subcutaneous Biologics
9.2 Traders or Distributors of Subcutaneous Biologics with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Subcutaneous Biologics
9.4 United States Import, Export and Trade Analysis of Subcutaneous Biologics

10 Development Trend of Subcutaneous Biologics Industry 2016-2021
10.1 Capacity and Production Overview of Subcutaneous Biologics 2016-2021
10.2 Production Market Share by Product Types of Subcutaneous Biologics 2016-2021
10.3 Sales and Sales Revenue Overview of Subcutaneous Biologics 2016-2021
10.4 United States Sales of Subcutaneous Biologics by Applications 2016-2021
10.5 Import, Export and Consumption of Subcutaneous Biologics 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Subcutaneous Biologics 2016-2021

11 Industry Chain Suppliers of Subcutaneous Biologics with Contact Information
11.1 Major Raw Materials Suppliers of Subcutaneous Biologics with Contact Information
11.2 Manufacturing Equipment Suppliers of Subcutaneous Biologics with Contact Information
11.3 Major Players of Subcutaneous Biologics with Contact Information
11.4 Key Consumers of Subcutaneous Biologics with Contact Information
11.5 Supply Chain Relationship Analysis of Subcutaneous Biologics

12 New Project Investment Feasibility Analysis of Subcutaneous Biologics
12.1 New Project SWOT Analysis of Subcutaneous Biologics
12.2 New Project Investment Feasibility Analysis of Subcutaneous Biologics

13 Conclusion of the United States Subcutaneous Biologics Industry 2016 Market Research Report